×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [15]
山东大学 [13]
复旦大学上海医学院 [13]
上海中医药大学 [3]
西安交通大学 [2]
四川大学 [2]
更多...
内容类型
期刊论文 [55]
会议论文 [3]
发表日期
2021 [1]
2019 [7]
2018 [9]
2017 [14]
2016 [6]
2015 [7]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共58条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
期刊论文
MOLECULAR BRAIN, 2021, 卷号: 14
作者:
Xu, Yanjun
;
Huang, Zhiyu
;
Yu, Xiaoqing
;
Chen, Kaiyan
;
Fan, Yun
收藏
  |  
浏览/下载:74/0
  |  
提交时间:2022/01/25
Brain metastases
Predictive biomarker
DNA methylation
Somatic mutation
Advanced non-small cell lung cancer (advanced NSCLC)
Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients
期刊论文
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 卷号: 234, 期号: 4
作者:
Miao, Ying-Ying
;
Liu, Gui-Feng
;
Zhang, Shu-Hua
;
Li, Xue-Feng
;
Yu, Shao-Nan
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
advanced or metastatic non-small-cell lung cancer (NSCLC)
adverse events
Bayesian network model
efficacy
randomized controlled trials
targeted agents
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study
期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2019, 卷号: 31, 期号: 2
作者:
Wu, Xianghua
;
Qin, Shanshan
;
Yu, Hui
;
Luo, Zhiguo
;
Wang, Huijie
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2019/12/05
Albumin-bound paclitaxel
cisplatin
gemcitabine
first-line therapy
advanced non-small-cell lung cancer
A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 10, 页码: S304-S304
作者:
Wu, Y.
;
Han, B.
;
Shi, M.
;
Tu, H.
;
Gu, A.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/11
advanced non-small cell lung cancer
Polymeric micelle paclitaxel
(pm-Pac) /cisplatin
randomized phase III clinical trial
Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy
期刊论文
FUTURE ONCOLOGY, 2019, 卷号: 15, 期号: 6, 页码: 625-635
作者:
Guo, Dong
;
Li, Minghuan
;
Chen, Dawei
;
Jing, Wang
;
Zhu, Hui
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/11
advanced
chemotherapy
first-line
neutrophil-to-lymphocyte ratio
non-small-cell lung cancer
platelet-to-lymphocyte ratio
platinum
predictor
prognostic
superior
Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC
期刊论文
INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 卷号: 72, 页码: 395-401
作者:
Guo, Meiying
;
Li, Wanlong
;
Li, Butuo
;
Zou, Bing
;
Wang, Shijiang
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/11
Locally advanced non-small cell lung cancer
Inflammatory biomarkers
Overall survival
Progression free survival
Nomogram
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 36
作者:
Zhou, Ming
;
Chen, Xiaoyuan
;
Zhang, Hong
;
Xia, Lin
;
Tong, Xin
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/01/03
Advanced non-small cell lung cancer
Anlotinib
Anti-angiogenesis
Epidermal growth factor receptor
Activating anaplastic lymphoma kinase
Adverse drug reaction
National Medical Products Administration
Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
期刊论文
2019, 卷号: 132, 期号: 8, 页码: 922-927
作者:
Yang, Wen-Hui
;
Xie, Jun
;
Lai, Zhi-Yong
;
Yang, Mu-Dan
;
Zhang, Ge-Hong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
Advanced non-small cell lung cancer
Chemotherapy
Combination therapy
Hyperthermia
Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer
期刊论文
JOURNAL OF BUON, 2018, 卷号: 23, 期号: 5
作者:
Duan, Jianchun
;
Yang, Zhenhua
;
Liu, Dingyuan
;
Zhang, Zhen
;
Shi, Yunfei
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/04
advanced non-small cell lung cancer
bevacizumab
survival rate
clinical effect
GP chemotherapy
A Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined with Yangzheng Xiaoji in Advanced NSCLC
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2018, 卷号: 13, 页码: S359-S360
作者:
Xing, L.
;
Wang, J.
;
Li, L.
;
Ma, Z.
;
Hu, C.
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/11/26
chemotherapy
Yangzheng Xiaoji (YZXJ)
Advanced Non-Small Cell Lung Cancer
©版权所有 ©2017 CSpace - Powered by
CSpace